"We provide the highest quality retinal care to our patients. Dr. Stephen Saxe and Dr. Raj Maturi personally provide all surgical and medical care to the referred patients."

During the past decade, Raj K. Maturi, MD, PC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 16 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Raj K. Maturi, MD, PC" #1 sponsor was "Maturi, Raj K., M.D., P.C." with 6 trials, followed by "Allergan" with 4 trials sponsored, "Jaeb Center for Health Research" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Allegro Ophthalmics, LLC" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Raj K. Maturi, MD, PC" #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Raj K. Maturi, MD, PC" are "Diabetic Macular Edema" (6 trials), "Macular Degeneration" (4 trials), "Age-Related Macular Degeneration" (3 trials), "Geographic Atrophy" (2 trials) and "Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Raj K. Maturi, MD, PC" in a lesser frequency.

Most popular intervention types in "Raj K. Maturi, MD, PC" are "Drug" (20 trials), "Other" (7 trials), "Device" (3 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (4 trials), "Faricimab" (3 trials), "Abicipar pegol" (2 trials), "Bevacizumab" (2 trials) and "Sham" (2 trials). Other intervention names were less common.

The vast majority of trials in "Raj K. Maturi, MD, PC" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Raj K. Maturi, MD, PC". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Raj K. Maturi, MD, PC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Raj K. Maturi, MD, PC, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".